Primary Job Title Chief Business Officer Primary Organization Vivoryon Therapeutics
Location Munich, Bayern, Germany Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Michael Schaeffer has been Chief Business Officer since October 1, 2018.Schaeffer brings more than 15 years of experience across pharma and biotech in strategic business development, scientific project and alliance management to Vivoryon Therapeutics. Schaeffer is a highly experienced serial entrepreneur and was prior to joining Probiodrug, –
amongst others – Founder, CEO and Managing Director of biotech companies, CRELUX GmbH and SiREEN AG. Following the acquisition of CRELUX by WuXiAppTec in 2016, Dr. Schaeffer was responsible for integrating CRELUX into the world-leading Shanghai based CRO with over 25,000 employees globally.
Schaeffer received his PhD in Molecular Biology from Ludwig-Maximilians-Universität in Munich, Germany and is an exceptionally skilled Operations- and Innovation Manager.
